Towards Precision Medicine in Systemic Lupus Erythematosus

Area of Science:

• Immunology
• Rheumatology
• Genetics

Background:

• Systemic lupus erythematosus (SLE) is a complex autoimmune disease.
• SLE is characterized by diverse clinical manifestations and immunological dysregulation.
• Current treatments for SLE include steroids, immunosuppressives, and hydroxychloroquine, often used broadly across patient groups.

Purpose of the Study:

• To review the major immunological changes involved in SLE pathophysiology.
• To discuss the challenges in applying precision medicine to SLE.
• To explore the potential for future personalized treatment strategies in SLE.

Main Methods:

• This is a review article.
• The review synthesizes current literature on SLE immunology and pathophysiology.
• It discusses the implications of immunological diversity for treatment.

Main Results:

• SLE exhibits significant heterogeneity in its immunological abnormalities.
• These diverse immunopathological profiles vary across different organs and systems affected by the disease.
• The broad application of similar drugs may not be optimal for all SLE patients.

Conclusions:

• The heterogeneity of SLE pathophysiology presents a significant hurdle for implementing precision medicine.
• Tailoring treatments based on precise immunopathological profiles will require further research.
• Achieving true precision medicine in SLE is a long-term goal.